Axim Biotechnologies

(OTC) AXIM

Current Price$0.01

Market Cap$1.87M

Since IPO (2013)-91%

5 Year-99%

1 Year-22%

1 Month-8%

Axim Biotechnologies Financials at a Glance

Market Cap

$1.87M

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.05M

EPS (TTM)

-$0.00

P/E Ratio

-1.62

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.01

Volume

44,120

Open

$0.01

Price

$0.01

Volume

44,120

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.03

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.01

Volume

44,120

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.03

AXIM News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Axim Biotechnologies

Industry

Biotechnology

Sector

Health Care

Employees

CEO

John W. Huemoeller, II

Website

www.aximbiotech.com

Headquarters

San Diego, CA 92121, US

AXIM Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

31%

Return on Assets

-16%

Earnings Yield

-61.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.87M

Shares Outstanding

340.46M

Volume

44.12K

Avg. Volume

216.56K

Financials (TTM)

Gross Profit

-$427.37K

Operating Income

-$1.32M

EBITDA

-$892.28K

Operating Cash Flow

-$686.21K

Capital Expenditure

$0.00

Free Cash Flow

-$686.21K

Cash & ST Invst.

$4.97K

Total Debt

$7.78M

Axim Biotechnologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$108.13K

-787.2%

Gross Margin

0.00%

N/A

Market Cap

$1.87M

N/A

Market Cap/Employee

$312.08K

N/A

Employees

N/A

Net Income

$135.92K

+106.0%

EBITDA

$328.35K

+117.1%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

-$7.54M

-17.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$7.44M

+17.9%

Short Term Debt

$101.55K

-45.2%

Return on Assets

-15.97%

N/A

Return on Invested Capital

31.21%

N/A

Free Cash Flow

-$673.59K

-221.8%

Operating Cash Flow

-$673.59K

-221.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PKTXProtoKinetix, Incorporated

PKTXProtoKinetix, Incorporated$0.01+0.00%

LVVVLiveWire Ergogenics, Inc.

LVVVLiveWire Ergogenics, Inc.$0.00+25.00%

SIGYSigyn Therapeutics, Inc.

SIGYSigyn Therapeutics, Inc.$0.04-7.89%

REPCFRepliCel Life Sciences Inc.

REPCFRepliCel Life Sciences Inc.$0.00+0.00%

RDDTFRadient Technologies Inc.

RDDTFRadient Technologies Inc.$0.00+0.00%

HAVLFHAVN Life Sciences Inc.

HAVLFHAVN Life Sciences Inc.$0.00+0.00%

ZLDAFZelira Therapeutics Limited

ZLDAFZelira Therapeutics Limited$0.35+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$114.68-0.05%

NOKNokia

NOKNokia$14.84-0.03%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.64-0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.92-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$84.56+0.01%

PATHUiPath

PATHUiPath$11.72+0.01%

Questions About AXIM

What is the current price of Axim Biotechnologies?

Axim Biotechnologies is trading at $0.01 per share.

What is the 52-week range for Axim Biotechnologies?

Over the past 52 weeks, Axim Biotechnologies has traded between $0.00 and $0.03.

How much debt does Axim Biotechnologies have?

As of the most recent reporting period, Axim Biotechnologies reported total debt of $7.35M.

How much cash does Axim Biotechnologies have on hand?

Axim Biotechnologies reported $2.80K in cash and cash equivalents in its most recent financial results.

What is Axim Biotechnologies’s dividend yield?

Axim Biotechnologies does not currently have a dividend yield.

Axim Biotechnologies

Axim Biotechnologies Financials at a Glance

AXIM News

3 Marijuana Stocks You Couldn't Pay Me to Buy

3 Marijuana Stocks That Like to Live Life Dangerously

2 Marijuana Stocks That Have Imploded Since August Began

2 Marijuana Stocks That Turned $10,000 Into $125,000 and $300,000, Respectively

This Marijuana Stock Is Up 2,500%, but It Has 2 Major Red Flags

The Average Marijuana Stock Is Up 332% Over the Past Year

3 Things You Need to Know About Marijuana Stock Axim Biotechnologies

4 Marijuana Stocks Looking to Combat the Opioid Epidemic

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Axim Biotechnologies

AXIM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Axim Biotechnologies Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AXIM

What is the current price of Axim Biotechnologies?

What is the 52-week range for Axim Biotechnologies?

How much debt does Axim Biotechnologies have?

How much cash does Axim Biotechnologies have on hand?

What is Axim Biotechnologies’s dividend yield?

Premium Investing Services